TY - JOUR
T1 - MCIP1 overexpression suppresses left ventricular remodeling and sustains cardiac function after myocardial infarction
AU - van Rooij, Eva
AU - Doevendans, Pieter A.
AU - Crijns, Harry J G M
AU - Heeneman, Sylvia
AU - Lips, Daniel J.
AU - van Bilsen, Marc
AU - Williams, R. Sanders
AU - Olson, Eric N.
AU - Bassel-Duby, Rhonda
AU - Rothermel, Beverly A.
AU - De Windt, Leon J.
N1 - Publisher Copyright:
© 2004 American Heart Association, Inc.
PY - 2004/2/20
Y1 - 2004/2/20
N2 - Pathological remodeling of the left ventricle (LV) after myocardial infarction (MI) is a major cause of heart failure. Although cardiac hypertrophy after increased loading conditions has been recognized as a clinical risk factor for human heart failure, it is unknown whether post-MI hypertrophic remodeling of the myocardium is beneficial for cardiac function over time, nor which regulatory pathways play a crucial role in this process. To address these questions, transgenic (TG) mice engineered to overexpress modulatory calcineurin-interacting protein-1 (MCIP1) in the myocardium were used to achieve cardiac-specific inhibition of calcineurin activation. MCIP1-TG mice and their wild-type (WT) littermates, were subjected to MI and analyzed 4 weeks later. At 4 weeks after MI, calcineurin was activated in the LV of WT mice, which was significantly reduced in MCIP1-TG mice. WT mice displayed a 78% increase in LV mass after MI, which was reduced by 38% in MCIP1-TG mice. Echocardiography indicated marked LV dilation and loss of systolic function in WT-MI mice, whereas TG-MI mice displayed a remarkable preservation of LV geometry and contractility, a pronounced reduction in myofiber hypertrophy, collagen deposition, and β-MHC expression compared with WT-MI mice. Together, these results reveal a protective role for MCIP1 in the post-MI heart and suggest that calcineurin is a crucial regulator of postinfarction-induced pathological LV remodeling. The improvement in functional, structural, and molecular abnormalities in MCIP1-TG mice challenges the adaptive value of post-MI hypertrophy of the remote myocardium. The full text of this article is available online at http://circres.ahajournals.org.
AB - Pathological remodeling of the left ventricle (LV) after myocardial infarction (MI) is a major cause of heart failure. Although cardiac hypertrophy after increased loading conditions has been recognized as a clinical risk factor for human heart failure, it is unknown whether post-MI hypertrophic remodeling of the myocardium is beneficial for cardiac function over time, nor which regulatory pathways play a crucial role in this process. To address these questions, transgenic (TG) mice engineered to overexpress modulatory calcineurin-interacting protein-1 (MCIP1) in the myocardium were used to achieve cardiac-specific inhibition of calcineurin activation. MCIP1-TG mice and their wild-type (WT) littermates, were subjected to MI and analyzed 4 weeks later. At 4 weeks after MI, calcineurin was activated in the LV of WT mice, which was significantly reduced in MCIP1-TG mice. WT mice displayed a 78% increase in LV mass after MI, which was reduced by 38% in MCIP1-TG mice. Echocardiography indicated marked LV dilation and loss of systolic function in WT-MI mice, whereas TG-MI mice displayed a remarkable preservation of LV geometry and contractility, a pronounced reduction in myofiber hypertrophy, collagen deposition, and β-MHC expression compared with WT-MI mice. Together, these results reveal a protective role for MCIP1 in the post-MI heart and suggest that calcineurin is a crucial regulator of postinfarction-induced pathological LV remodeling. The improvement in functional, structural, and molecular abnormalities in MCIP1-TG mice challenges the adaptive value of post-MI hypertrophy of the remote myocardium. The full text of this article is available online at http://circres.ahajournals.org.
KW - Calcineurin
KW - Heart failure
KW - Hypertrophy
KW - Myocardial infarction
KW - Signaling
UR - http://www.scopus.com/inward/record.url?scp=2442420976&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=2442420976&partnerID=8YFLogxK
U2 - 10.1161/01.RES.0000118597.54416.00
DO - 10.1161/01.RES.0000118597.54416.00
M3 - Article
C2 - 14739160
AN - SCOPUS:2442420976
SN - 0009-7330
VL - 94
SP - e18-e26
JO - Circulation research
JF - Circulation research
IS - 3
ER -